๐
Jelrix
autologous cartilage-derived articular chondrocytes, in-vitro expanded
Knee Injuries;Cartilage Diseases;Knee Joint
๐ซ Withdrawn
Advanced therapy
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Repair of symptomatic, localised, full-thickness cartilage defects of the knee joint grade III or IV
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/jelrix